Is mitochondrial dysfunction a cause of insulin resistance?

Trends in Endocrinology and Metabolism

Volumn 19, Issue 9, 2008, Pages 324-330

  Turner, Nigel ^a   Heilbronn, Leonie K ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; ADENOSINE TRIPHOSPHATE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RESVERATROL; RNA DIRECTED DNA POLYMERASE INHIBITOR; ROSIGLITAZONE;

BIOGENESIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GLYCOLYSIS; HEREDITY; HUMAN; INSULIN RESISTANCE; MITOCHONDRIAL RESPIRATION; MUSCLE MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SITTING;

ANIMALS; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MITOCHONDRIA, MUSCLE; MODELS, BIOLOGICAL; MUSCLE, SKELETAL;

EID: 53649083550     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2008.08.001     Document Type: Review

References (78)

1. Wild S., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Hegarty B.D., et al. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51 (2002) 1477-1484
3. Bonen A., et al. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 18 (2004) 1144-1146
4. Lowell B.B., and Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 307 (2005) 384-387
5. Choo H.J., et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49 (2006) 784-791
6. Bugger H., and Abel E.D. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin. Sci. (Lond.) 114 (2008) 195-210
7. Kim J.Y., et al. Lipid oxidation is reduced in obese human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E1039-E1044
8. Simoneau J.A., et al. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J. 13 (1999) 2051-2060
9. Kelley D.E., et al. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am. J. Physiol. 277 (1999) E1130-E1141
10. Kelley D.E., et al. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51 (2002) 2944-2950
11. Patti M.E., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8466-8471
12. Mootha V.K., et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 (2003) 267-273
13. Morino K., et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 115 (2005) 3587-3593
14. Heilbronn L.K., et al. Markers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects. J. Clin. Endocrinol. Metab. 92 (2007) 1467-1473
15. Skov V., et al. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes 56 (2007) 2349-2355
16. Boushel R., et al. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50 (2007) 790-796
17. Ritov V.B., et al. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54 (2005) 8-14
18. Petersen K.F., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 (2003) 1140-1142
19. Schrauwen-Hinderling V.B., et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50 (2007) 113-120
20. Szendroedi J., et al. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med. 4 (2007) e154
21. Befroy D.E., et al. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes 56 (2007) 1376-1381
22. Petersen K.F., et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350 (2004) 664-671
23. Petersen K.F., et al. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med. 2 (2005) e233
24. Bandyopadhyay G.K., et al. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 55 (2006) 2277-2285
25. Holloway G.P., et al. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1782-E1789
26. Mogensen M., et al. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56 (2007) 1592-1599
27. Fleischman A., et al. Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1666-E1673
28. Brehm A., et al. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 55 (2006) 136-140
29. Hoeks J., et al. Peroxisome proliferator-activated receptor-γ coactivator-1 and insulin resistance: acute effect of fatty acids. Diabetologia 49 (2006) 2419-2426
30. Richardson D.K., et al. Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle. J. Biol. Chem. 280 (2005) 10290-10297
31. Sparks L.M., et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54 (2005) 1926-1933
32. Lionetti L., et al. Skeletal muscle subsarcolemmal mitochondrial dysfunction in high-fat fed rats exhibiting impaired glucose homeostasis. Int. J. Obes. (Lond). 31 (2007) 1596-1604
33. Jove M., et al. Impaired expression of NADH dehydrogenase subunit 1 and PPARγ coactivator-1 in skeletal muscle of ZDF rats: restoration by troglitazone. J. Lipid Res. 45 (2004) 113-123
34. Bonnard C., et al. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J. Clin. Invest. 118 (2008) 789-800
35. Rimbert V., et al. Muscle fat oxidative capacity is not impaired by age but by physical inactivity: association with insulin sensitivity. FASEB J. 18 (2004) 737-739
36. Ostergard T., et al. Impact of exercise training on insulin sensitivity, physical fitness, and muscle oxidative capacity in first-degree relatives of type 2 diabetic patients. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E998-E1005
37. Toledo F.G., et al. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes 56 (2007) 2142-2147
38. Larson-Meyer D.E., et al. Effect of calorie restriction with or without exercise on insulin sensitivity, β-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care 29 (2006) 1337-1344
39. Weiss E.P., et al. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am. J. Clin. Nutr. 84 (2006) 1033-1042
40. Civitarese A.E., et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 4 (2007) e76
41. Nisoli E., et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310 (2005) 314-317
42. Lagouge M., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127 (2006) 1109-1122
43. Ling C., et al. Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J. Clin. Invest. 117 (2007) 3427-3435
44. Liang P., et al. Increased prevalence of mitochondrial DNA deletions in skeletal muscle of older individuals with impaired glucose tolerance: possible marker of glycemic stress. Diabetes 46 (1997) 920-923
45. Barroso I., et al. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 49 (2006) 501-505
46. Ukropcova B., et al. Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. J. Clin. Invest. 115 (2005) 1934-1941
47. Hulver M.W., et al. Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab. 2 (2005) 251-261
48. Hoppeler H., and Fluck M. Plasticity of skeletal muscle mitochondria: structure and function. Med. Sci. Sports Exerc. 35 (2003) 95-104
49. Levine J.A., et al. Interindividual variation in posture allocation: possible role in human obesity. Science 307 (2005) 584-586
50. Hamilton M.T., et al. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 56 (2007) 2655-2667
51. Levine J.A., et al. The role of free-living daily walking in human weight gain and obesity. Diabetes 57 (2008) 548-554
52. Andreyev A.Y., et al. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc.) 70 (2005) 200-214
53. Choksi K.B., et al. Oxidatively damaged proteins of heart mitochondrial electron transport complexes. Biochim. Biophys. Acta 1688 (2004) 95-101
54. Lesnefsky E.J., et al. Cardiolipin as an oxidative target in cardiac mitochondria in the aged rat. Biochim. Biophys. Acta 1777 (2008) 1020-1027
55. Schrauwen P., and Hesselink M.K. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53 (2004) 1412-1417
56. Evans J.L., et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23 (2002) 599-622
57. Stump C.S., et al. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7996-8001
58. Asmann Y.W., et al. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 55 (2006) 3309-3319
59. Karakelides H., et al. Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects. Diabetes 56 (2007) 2683-2689
60. Nair K.S., et al. Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 57 (2008) 1166-1175
61. De Feyter H.M., et al. Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction. Eur. J. Endocrinol. 158 (2008) 643-653
62. Bajaj M., et al. Paradoxical changes in muscle gene expression in insulin-resistant subjects after sustained reduction in plasma free fatty acid concentration. Diabetes 56 (2007) 743-752
63. Toledo F.G., et al. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content. Diabetes 57 (2008) 987-994
64. Schrauwen-Hinderling V.B., et al. The insulin sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function. J. Clin. Endocrinol. Metab. 93 (2008) 2917-2921
65. Wredenberg A., et al. Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochem. Biophys. Res. Commun. 350 (2006) 202-207
66. Pospisilik J.A., et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131 (2007) 476-491
67. Handschin C., et al. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1α knockout mice reveals skeletal muscle-pancreatic β cell crosstalk. J. Clin. Invest. 117 (2007) 3463-3474
68. Vianna C.R., et al. Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance. Cell Metab. 4 (2006) 453-464
69. Calvo J.A., et al. Muscle-specific expression of PPARγ coactivator-1α improves exercise performance and increases peak oxygen uptake. J. Appl. Physiol. 104 (2008) 1304-1312
70. de Wilde J., et al. Short-term high fat-feeding results in morphological and metabolic adaptations in the skeletal muscle of C57BL/6J mice. Physiol. Genomics 32 (2008) 360-369
71. Turner N., et al. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56 (2007) 2085-2092
72. Hancock C.R., et al. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 7815-7820
73. Koves T.R., et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7 (2008) 45-56
74. Bangsbo J. Muscle oxygen uptake in humans at onset of and during intense exercise. Acta Physiol. Scand. 168 (2000) 457-464
75. Savage D.B., et al. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87 (2007) 507-520
76. Holland W.L., et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5 (2007) 167-179
77. Yu C., et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277 (2002) 50230-50236
78. Hegarty B.D., et al. The role of intramuscular lipid in insulin resistance. Acta Physiol. Scand. 178 (2003) 373-383